Logiscreen

Organon & Company

$13.36
Market Cap 3.48B
ROE 29.9%
Gross Margin 53.6%
Debt/Equity 9.5
Current Ratio 2.0
Revenue QoQ -3.5%
EPS QoQ 0.6%
F-Score 7

About

Organon & Company

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
14.18
vs median 33.61
P/B
3.86
vs median 2.16
ROE
0.30
vs median 0.09

High quality company with strong fundamentals

Mid-cap company with growth potential

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics